Turner Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-15,010
Closed -$1.25M 198
2016
Q2
$1.25M Buy
+15,010
New +$1.33M 0.39% 79
2016
Q1
Sell
-33,650
Closed -$3.4M 228
2015
Q4
$3.4M Buy
33,650
+8,700
+35% +$905K 0.7% 52
2015
Q3
$2.45M Buy
+24,950
New +$2.77M 0.5% 70
2015
Q1
Sell
-20,292
Closed -$1.91M 461
2014
Q4
$1.91M Sell
20,292
-6,446
-24% -$667K 0.23% 143
2014
Q3
$2.85M Buy
26,738
+15,962
+148% +$1.56M 0.17% 175
2014
Q2
$893K Sell
10,776
-67,345
-86% -$5.24M 0.04% 388
2014
Q1
$5.54M Sell
78,121
-721,427
-90% -$56.6M 0.15% 196
2013
Q4
$60M Sell
799,548
-82,659
-9% -$5.76M 1.07% 7
2013
Q3
$55.5M Sell
882,207
-378,184
-30% -$22.6M 0.92% 14
2013
Q2
$64.6M Buy
+1,260,391
New +$65.7M 0.87% 10

Other funds holding GILD

Turner Investments's GILD Position: Q3 2016 in Review

Turner Investments sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 15,010 shares — an estimated $1.25M sold.

Turner Investments first reported a position in GILD in Q2 2013 and held it in 10 quarters. The position peaked at $64.6M in Q2 2013. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Turner Investments reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Turner Investments sold 15,010 Gilead Sciences shares in Q3 2016, an estimated $1.25M.
  • Turner Investments first reported a position in Gilead Sciences in Q2 2013 and held it in 10 quarters.
  • Turner Investments's Gilead Sciences position peaked at $64.6M in Q2 2013.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Turner Investments's 13F filing for Q3 2016, filed 14 Nov 2016.